Transform Wealth LLC Cuts Stake in The Allstate Co. (NYSE:ALL)

Transform Wealth LLC lowered its holdings in shares of The Allstate Co. (NYSE:ALL) by 6.5% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 7,583 shares of the insurance provider’s stock after selling 527 shares during the period. Transform Wealth LLC’s holdings in Allstate were worth $1,469,000 as of its most recent filing with the SEC.

Other large investors also recently added to or reduced their stakes in the company. State Street Corp lifted its position in Allstate by 1.1% in the third quarter. State Street Corp now owns 11,496,306 shares of the insurance provider’s stock valued at $2,190,758,000 after purchasing an additional 126,922 shares during the last quarter. Geode Capital Management LLC increased its stake in shares of Allstate by 1.2% in the third quarter. Geode Capital Management LLC now owns 6,228,581 shares of the insurance provider’s stock worth $1,178,164,000 after buying an additional 74,537 shares during the period. Allspring Global Investments Holdings LLC raised its holdings in Allstate by 18.7% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 3,000,866 shares of the insurance provider’s stock valued at $569,114,000 after buying an additional 472,040 shares during the last quarter. Raymond James & Associates boosted its position in Allstate by 10.6% during the 3rd quarter. Raymond James & Associates now owns 1,517,800 shares of the insurance provider’s stock valued at $287,851,000 after buying an additional 145,986 shares during the period. Finally, Pathway Financial Advisers LLC grew its holdings in Allstate by 18,472.5% in the 3rd quarter. Pathway Financial Advisers LLC now owns 1,052,687 shares of the insurance provider’s stock worth $199,642,000 after acquiring an additional 1,047,019 shares during the last quarter. Hedge funds and other institutional investors own 76.47% of the company’s stock.

Allstate Stock Performance

Shares of NYSE ALL opened at $188.85 on Tuesday. The company has a current ratio of 0.40, a quick ratio of 0.40 and a debt-to-equity ratio of 0.43. The Allstate Co. has a 12-month low of $150.17 and a 12-month high of $209.88. The firm has a market capitalization of $50.01 billion, a price-to-earnings ratio of 12.23, a price-to-earnings-growth ratio of 1.42 and a beta of 0.52. The firm has a 50 day moving average of $195.55 and a 200 day moving average of $186.90.

Allstate (NYSE:ALL) last released its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.20 by $1.71. Allstate had a return on equity of 26.67% and a net margin of 6.77%. The business had revenue of $16.63 billion during the quarter, compared to analyst estimates of $14.57 billion. During the same quarter in the previous year, the company posted $0.81 earnings per share. Allstate’s revenue for the quarter was up 14.7% on a year-over-year basis. On average, research analysts anticipate that The Allstate Co. will post 16.45 earnings per share for the current year.

Allstate Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, January 2nd. Shareholders of record on Friday, November 29th were issued a dividend of $0.92 per share. The ex-dividend date was Friday, November 29th. This represents a $3.68 dividend on an annualized basis and a yield of 1.95%. Allstate’s dividend payout ratio is presently 23.83%.

Analyst Upgrades and Downgrades

ALL has been the subject of a number of recent analyst reports. The Goldman Sachs Group upped their target price on Allstate from $209.00 to $230.00 and gave the company a “buy” rating in a report on Friday, November 15th. BMO Capital Markets upped their price objective on shares of Allstate from $205.00 to $214.00 and gave the stock an “outperform” rating in a report on Friday, October 18th. Wells Fargo & Company lifted their target price on shares of Allstate from $186.00 to $187.00 and gave the company an “equal weight” rating in a research note on Tuesday, January 14th. Keefe, Bruyette & Woods increased their price target on shares of Allstate from $235.00 to $243.00 and gave the stock an “outperform” rating in a research note on Friday, January 10th. Finally, Jefferies Financial Group lifted their price objective on Allstate from $231.00 to $267.00 and gave the company a “buy” rating in a research report on Friday, November 8th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, Allstate has a consensus rating of “Moderate Buy” and a consensus price target of $218.13.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.